Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

PURPOSE: Preclinical models suggest that the use of anti–vascular endothelial growth factor (anti-VEGF) therapy with antiestrogens may prevent or delay the development of endocrine therapy resistance. We therefore performed a feasibility study to evaluate the safety of letrozole plus bevacizumab in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Traina, Tiffany A., Rugo, Hope S., Caravelli, James F., Patil, Sujata, Yeh, Benjamin, Melisko, Michele E., Park, John W., Geneus, Stephanie, Paulson, Matthew, Grothusen, Jill, Seidman, Andrew D., Fornier, Monica, Lake, Diana, Dang, Chau, Robson, Mark, Theodoulou, Maria, Flombaum, Carlos D., Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2010
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3940895/
https://ncbi.nlm.nih.gov/pubmed/19841327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8784
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller